NFL Biosciences SA

Paris Stock Exchange ALNFL.PA

NFL Biosciences SA Dividend Per Share for the year ending December 31, 2023

NFL Biosciences SA Dividend Per Share is NA for the year ending December 31, 2023. Dividend per share represents the dividends distributed per share. Indicates dividend yield potential on a per-share basis.
Key data
Date Dividend Per Share Free Cash Flow Per Share Return on Assets (ROA) Return on Equity (ROE)
Market news
SV Wall Street
Paris Stock Exchange: ALNFL.PA

NFL Biosciences SA

CEO Dr. Ignacio Faus M.B.A., Ph.D.
IPO Date July 5, 2021
Location France
Headquarters 199 Rue Helene Boucher
Employees 4
Sector Health Care
Industries
Biotechnology Pharmaceuticals Tobacco
Description

NFL Biosciences SA, a biotechnology company, develops natural addiction withdrawal solutions for smokers. Its natural drug candidate in pipeline to cure tobacco addiction include NFL-101, a tobacco extract that is in Phase III clinical trial targeting smoking addiction; NFL-201, a cannabis and tobacco extract, which is in preclinical stage; and NFL-301, a botanical extract (traditional Chinese medicine) that is in preclinical stage. The company was incorporated in 2006 and is based in Castelnau-le-Lez, France.

Similar companies

ABNX.PA

ABIONYX Pharma SA

USD 1.28

-1.09%

StockViz Staff

January 31, 2025

Any question? Send us an email